Pharmacovigilance Market: Case Processing Automation, Workflow Efficiency & Growth Outlook

According to IMARC Group's latest research publication, global pharmacovigilance market size reached USD 8.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 16.3 Billion by 2034, exhibiting a growth rate (CAGR) of 7.5% during 2026-2034.

How AI is Reshaping the Future of Pharmacovigilance Market

• Natural Language Processing for Literature Monitoring: Large language models automate literature screening with high sensitivity and reproducibility, efficiently identifying relevant safety articles and filtering irrelevant publications.
• Predictive Risk Analytics and Real-World Evidence: AI enables proactive surveillance by predicting adverse drug reactions and drug-drug interactions before they manifest widely in patient populations.
• Quality Control and Duplicate Detection: Automated systems enhance data precision by identifying duplicate case reports and performing quality checks across global safety databases.

View Comprehensive 2026 Industry Forecasts

Pharmacovigilance Industry Overview:

The pharmacovigilance sector is experiencing a transformation driven by regulatory intensification and technological adoption. The FDA's CDER Emerging Drug Safety Technology Program launched in 2024 specifically focuses on integrating AI and emerging technologies across the drug product lifecycle. With over 22,000 clinical trials initiated in 2023 and pharmaceutical companies facing exponentially growing adverse event reports, the demand for intelligent automation has become urgent.

Pharmacovigilance Market Trends & Drivers:

The complexity of modern drug development is reshaping pharmacovigilance demands across the industry. Biologics, gene therapies, and personalized medicine treatments require sophisticated safety monitoring beyond traditional approaches. According to recent health data, an estimated 129 million people in the U.S. live with at least one major chronic disease such as heart disease, cancer, or diabetes, driving continuous medication use and increasing polypharmacy risks.

Regulatory requirements continue to tighten worldwide, creating sustained demand for comprehensive pharmacovigilance systems. The FDA enforces robust adverse event reporting obligations under 21 CFR 314.80 and related regulations, requiring pharmaceutical companies to review all adverse drug experience information and submit timely reports. European agencies through the EU Pharmacovigilance Directive mandate stringent safety monitoring and risk management plans throughout product lifecycles.

The strategic shift toward outsourcing pharmacovigilance functions is accelerating as companies seek operational efficiency and expertise. Contract outsourcing accounted for 61.2% of market activity as pharmaceutical and biotechnology firms redirect resources toward core competencies like drug discovery while entrusting safety monitoring to specialized organizations.

Leading Companies Operating in the Global Pharmacovigilance Industry:

• Accenture plc
• ArisGlobal LLC
• BioClinica Inc. (Cinven Partners LLP)
• Capgemini
• Cognizant
• International Business Machines Corporation
• ICON plc.
• IQVIA Inc.
• ITClinical
• Parexel International Corporation
• Wipro Limited

Pharmacovigilance Market Report Segmentation:

By Service Provider:

• In-house
• Contract Outsourcing

Contract outsourcing represents the largest segment, as it is more affordable and productive in terms of compliance with regulatory requirements and risk monitoring.

By Product Life Cycle:

• Pre-clinical
• Phase I
• Phase II
• Phase III
• Phase IV

Phase IV or the post-marketing surveillance phase has the biggest market share of 76.5% in the pharmacovigilance market as the monitoring of drug safety after approval is crucial.

By Type:

• Spontaneous Reporting
• Intensified ADR Reporting
• Targeted Spontaneous Reporting
• Cohort Event Monitoring
• EHR Mining

The global pharmacovigilance market is led by the spontaneous reporting method with a share of 31.9% due to its high usage in identifying ADRs at a relatively low cost and time.

By Process Flow:

• Case Data Management
• Case Logging
• Case Data Analysis
• Medical Reviewing and Reporting
• Signal Detection
• Adverse Event Logging
• Adverse Event Analysis
• Adverse Event Review and Reporting
• Risk Management System
• Risk Evaluation System
• Risk Mitigation System

Signal detection constitutes the largest segment of the pharmacovigilance market with a market share of 38.2% because it plays a central role in detecting and managing safety concerns.

By Therapeutic Area:

• Oncology
• Neurology
• Cardiology
• Respiratory Systems
• Others

The pharmacovigilance market is led by oncology as it has the largest market share of 27.8%.

By End Use:

• Pharmaceuticals Companies
• Biotechnology Companies
• Medical Device Companies
• Others

The largest segment in the pharmacovigilance market is occupied by pharmaceutical companies with a share of 44.2% because of their significant responsibilities within drug development and safety.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America exhibits a clear dominance in the pharmacovigilance market with 33.7% market share due to the presence of an advanced healthcare system.

Recent News and Developments in Pharmacovigilance Market

• March 2025: Tech Mahindra and NVIDIA collaborated to develop an agentic AI-powered pharmacovigilance solution that enhances drug safety management by automating and optimizing workflows.
• March 2025: ArisGlobal launched three new AI-driven products at Breakthrough 2025: LifeSphere Unify, NavaX Insights, and Advanced Compliance Docs.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.